| Respiratory Syncytial Virus (RSV) Infection |
1 |
1 |
| Hospital |
0 |
0.6 |
| Intensive Care Unit |
0 |
0.46 |
| Immunization |
0 |
0.43 |
| Coronary Artery Disease (CAD) |
0 |
0.42 |
| Heart |
0 |
0.34 |
| Germany |
0 |
0.26 |
| Cardiovascular Risk Management |
0 |
0.99 |
| Influenza |
0 |
0.18 |
| Cardiovascular disease |
0 |
0.17 |
| Heart Failure (HF) |
0 |
0.14 |
| Arrhythmia |
0 |
0.13 |
| Cardiogenic Shock |
0 |
0.12 |
| Ventricular Tachycardia |
0 |
0.12 |
| Acute Heart Failure (HF) |
0 |
0.1 |
| Airway |
0 |
0.09 |
| Artificial Intelligence |
0 |
0.09 |
| Dyspnea |
0 |
0.09 |
| Epidemiology |
0 |
0.09 |
| Epithelium |
0 |
0.09 |
| Impairment |
0 |
0.09 |
| Pandemic |
0 |
0.09 |
| Prognosis |
0 |
0.09 |
| Respiratory Tract |
0 |
0.09 |
| Shock |
0 |
0.09 |
| Tachycardia |
0 |
0.09 |
| Targeted Cancer Therapy |
0 |
0.09 |
| Trachea |
0 |
0.09 |
| Vaccines for Adult |
0 |
0.09 |
| COVID-19 |
0 |
0.08 |